Laverock Therapeutics-preview

Laverocktx

Laverock Therapeutics

Private

LondonHealthcare & Life Scienceshttps://www.laverocktx.com/

Last Round

Seed

Jun 30, 2025

Total Funding Raised

$26.58M

Company Overview

Laverock Therapeutics is a biotechnology company that develops a gene silencing platform designed to engineer programmable and adaptive cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

gene silencingGEiGScell therapygene therapyCGTRNA interferenceRNAigene editingimmuno-oncologyIOcell engineeringprogrammable medicineregenerative medicinelogic-gated therapiesbiotech platformsynthetic biologyT-cell therapytherapeutic licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Laverock Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Laverock Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jun 30, 2025
Grant	Oct 30, 2023
Seed	Sep 28, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Lisa Deschamps

Chief Executive Officer Board Member

Executive Team

Tim Allsopp

CTO P T

Executive Team

Sandy McDougall

Chief Financial Officer

Executive Team

Tom Payne

Chief Operating Officer

Executive Team

View all key people

Laverock Therapeutics Investors

Notable investors and investment history

Investor	Rounds
Mercia Ventures	Seed
Tekfen Ventures	Seed
Innovate UK	Grant
Calculus Capital	Seed
Eos Advisory	Seed
UK Innovation & Science Seed Fund	Seed, Grant
Norcliffe Capital Limited	Seed

View all Investors

Laverock Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Laverock Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Laverock Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range37

Year Founded2021

Last FundingJun 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.